The observations do not pose any risk to site's compliance standards or its business continuity
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated